COMPARISON OF TWO ANALGESIA DRUGS WHICH IS GIVEN DURING UPPER ARM PROCEDURES

To evaluate the effect of dexmedetomidine and buprenorphine as an adjuvant to ropivacaine under peripheral nerve stimulator guided supraclavicular block for upper limb surgeries - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/062594

Enrollment

Registered

2024-02-13

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: S598- Other specified injuries of elbowand forearm

Interventions

Intervention1: Dexmeditomedine 100mcg will be used as intervention: In intervention group we will assess the effect of dexmeditomedine 100mcg with ropivacaine 0.5% in supraclavicular block for upper

Eligibility

Inclusion criteria

Inclusion criteria: ASA GRADE 1 & 2 PATIENT WILLING INFORMED AND WRITTEN CONSENT

Exclusion criteria

Exclusion criteria: PATIENT REFUSAL ALLERGY TO LOCAL ANAESTHETIC AND OPIOIDS LOCAL INFECTION AT SITE OF BLOCK PREGNANT PATIENTS

Design outcomes

Primary

Measure	Time frame
local dexmeditomedine 100mcg with 0.5% ropivacaine for upper limb orthopedic surgeries achived significant analgesia and prolong post operative pain relief compared to buprenorphine 300mcg with 0.5% ropivacaine.Timepoint: 2 YEARS	—

Secondary

Measure	Time frame
ONSET AND DURATION OD MOTOR BLOCKADE ONSET AND DURATION OF SENSORY BLOCKADE HEMODYNAMIC STABILITY SIDE EFFECTS IF ANYTimepoint: 2 YEARS	—

Countries

India

Contacts

Public ContactNandha Kumar

Datta Meghe Institute of Higher Education and Research

karunahp1878@gmail.com7722037738

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026